KRYS Stock Summary and Trading Ideas (Krystal Biotech | NASDAQ:KRYS)

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

What symbol and exchange does Krystal Biotech shares trade?

Krystal Biotech trades on the NASDAQ stock market under the symbol KRYS.

What is Krystal Biotech stock price doing today?

As of February 27, 2026, KRYS stock price declined to $275.64 with 195,018 million shares trading.

What is Krystal Biotech's Beta?

KRYS has a beta of 0.14, meaning it tends to be less sensitive to market movements. KRYS has a correlation of 0.00 to the broad based SPY ETF.

How much is Krystal Biotech worth?

KRYS has a market cap of $8.06 billion. This is considered a Mid Cap stock.

How much money does Krystal Biotech make?

Last quarter Krystal Biotech reported $107 million in Revenue and $1.70 earnings per share. This beat revenue expectation by $583,000 and exceeded earnings estimates by $.09.

What is the highest and lowest price Krystal Biotech traded in the last 3 year period?

In the last 3 years, KRYS traded as high as $298.30 and as low as $70.51.

What are the top ETFs holding Krystal Biotech?

The top ETF exchange traded funds that KRYS belongs to (by Net Assets): IJR, VTI, VB, IWM, XBI.

Is Krystal Biotech (KRYS) a good investment?

KRYS has outperformed the market in the last year with a return of +59.0%, while the SPY ETF gained +18.5%. In the last 3 month period, KRYS beat the market returning +26.0%, while SPY returned +1.2%. However, in the most recent 2 weeks KRYS has underperformed the stock market by returning -0.3%, while SPY returned +0.6%.

What are the support and resistance levels for Krystal Biotech (KRYS)?

KRYS support price is $267.15 and resistance is $285.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRYS shares will trade within this expected range on the day.